microRNA-based autophagy inhibition as targeted therapy in pancreatic cancer
Open Access
- 6 October 2020
- journal article
- review article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 132, 110799
- https://doi.org/10.1016/j.biopha.2020.110799
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- The Duality of OncomiR Addiction in the Maintenance and Treatment of CancerThe Cancer Journal, 2012
- Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic CancersPLOS ONE, 2012
- Pancreatic cancers require autophagy for tumor growthGenes & Development, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature, 2011
- ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy MachineryMolecular Biology of the Cell, 2009
- Nutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for AutophagyMolecular Biology of the Cell, 2009
- Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real‐Time PCR AnalysisWorld Journal of Surgery, 2008
- The Atg16L Complex Specifies the Site of LC3 Lipidation for Membrane Biogenesis in AutophagyMolecular Biology of the Cell, 2008
- Expression profiling identifies microRNA signature in pancreatic cancerInternational Journal of Cancer, 2006